Trial Profile
Clinical Trials Insight: 700057614
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Jul 2010
Price :
$35
*
At a glance
- Drugs Fasiglifam (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 13 Jul 2010 New trial record
- 24 Jun 2010 Results have been presented at the 70th Annual Scientific Sessions of the American Diabetes Association (ADA 2010).